“…It is not fully understood which are the causes related to abnormal breathing in RTT, but studies suggest the involvement of norepinephrine (Viemari et al, 2005), neurotrophic factors like BDNF (Li & Pozzo‐Miller, 2014), dysregulation of expression of 5‐ht5b‐receptors (Vogelgesang, Niebert, Bischoff, Hülsmann, & Manzke, 2018) or decrease in excitatory synaptic connectivity in several parts of brain cortex, including the medial prefrontal cortex (Sceniak et al, 2016). Studies on MECP2 ‐null mice show also an altered sensitivity to blood gases: increased hypoxia susceptibility associated with failure to increase ventilation in presence of moderate hypercapnia (Jiang, Cui, Zhong, Johnson, & Wu, 2017). The clinical spectrum of disorders, particularly of breathing behavior, related to MECP2 mutations in males is not fully understood.…”